These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16288834)

  • 1. Is slow coronary flow associated with inflammation?
    Li JJ; Xu B; Li ZC; Qian J; Wei BQ
    Med Hypotheses; 2006; 66(3):504-8. PubMed ID: 16288834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins may be beneficial for patients with slow coronary flow syndrome due to its anti-inflammatory property.
    Li JJ; Zheng X; Li J
    Med Hypotheses; 2007; 69(2):333-7. PubMed ID: 17215087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary slow flow phenomenon: a local or systemic disease?
    Wang X; Geng LL; Nie SP
    Med Hypotheses; 2010 Sep; 75(3):334-7. PubMed ID: 20385447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation: a possible pathogenic link to cardiac syndrome X.
    Li JJ; Li YS; Zhang Y; Gao Z; Li Z; Qian HY
    Med Hypotheses; 2006; 66(1):87-91. PubMed ID: 16182462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The coronary slow flow phenomenon: a new cardiac "Y" syndrome?
    Leone MC; Gori T; Fineschi M
    Clin Hemorheol Microcirc; 2008; 39(1-4):185-90. PubMed ID: 18503124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of coronary blood flow during exercise.
    Duncker DJ; Bache RJ
    Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should slow coronary flow be considered as a coronary syndrome?
    Li JJ; Wu YJ; Qin XW
    Med Hypotheses; 2006; 66(5):953-6. PubMed ID: 16413138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The "slow coronary flow" phenomenon: evidence of preserved coronary flow reserve despite increased resting microvascular resistances.
    Fineschi M; Bravi A; Gori T
    Int J Cardiol; 2008 Jul; 127(3):358-61. PubMed ID: 17651842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased plasma C-reactive protein and interleukin-6 concentrations in patients with slow coronary flow.
    Li JJ; Qin XW; Li ZC; Zeng HS; Gao Z; Xu B; Zhang CY; Li J
    Clin Chim Acta; 2007 Oct; 385(1-2):43-7. PubMed ID: 17706955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation in variant angina: is there any evidence?
    Li JJ; Nie SP; Xu B; Guo YL; Gao Z; Zheng X
    Med Hypotheses; 2007; 68(3):635-40. PubMed ID: 17030449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin may improve myocardial perfusion abnormality in slow coronary flow.
    Cakmak M; Tanriverdi H; Cakmak N; Evrengul H; Cetemen S; Kuru O
    Cardiology; 2008; 110(1):39-44. PubMed ID: 17934268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and coronary angiographic characteristics of patients with coronary slow flow.
    Yilmaz H; Demir I; Uyar Z
    Acta Cardiol; 2008 Oct; 63(5):579-84. PubMed ID: 19014000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin activatable fibrinolysis inhibitor : its role in slow coronary flow.
    Yildirim MN; Selcoki Y; Uysal S; Nacar AB; Demircelik B; Aydin HI; Eryonucu B
    Herz; 2014 Dec; 39(8):993-1000. PubMed ID: 24068025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does coronary slow flow phenomenon lead to myocardial ischemia?
    Tatli E; Yildirim T; Aktoz M
    Int J Cardiol; 2009 Jan; 131(3):e101-2. PubMed ID: 17931724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The predictive value of brachial-ankle pulse wave velocity in coronary atherosclerosis and peripheral artery diseases in urban Chinese patients.
    Xu Y; Wu Y; Li J; Ma W; Guo X; Luo Y; Hu D
    Hypertens Res; 2008 Jun; 31(6):1079-85. PubMed ID: 18716354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCL16 is a marker of inflammation, atherosclerosis, and acute coronary syndromes in humans.
    Lehrke M; Millington SC; Lefterova M; Cumaranatunge RG; Szapary P; Wilensky R; Rader DJ; Lazar MA; Reilly MP
    J Am Coll Cardiol; 2007 Jan; 49(4):442-9. PubMed ID: 17258089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The coronary slow flow phenomenon--a new coronary microvascular disorder.
    Beltrame JF; Limaye SB; Horowitz JD
    Cardiology; 2002; 97(4):197-202. PubMed ID: 12145474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is any link between inflammation and coronary artery ectasia?
    Li JJ; Li Z; Li J
    Med Hypotheses; 2007; 69(3):678-83. PubMed ID: 17222519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Coronary microcirculation. Pathophysiology, clinical relevance, and importance for regenerative therapy after myocardial infarction].
    Schächinger V; Zeiher AM
    Herz; 2005 Nov; 30(7):641-50. PubMed ID: 16333592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.